# Basecamp Research

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/basecamp-research

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.basecamp-research.com
- Total disclosed funding: $217M
- Latest round: Series C (Sep 22, 2026)
- Investors on record: 19

## About

Based in London, UK, and founded in 2019, Basecamp Research Ltd operates as a biotechnology company. The company was founded by Oliver Vince and Glen Gowers. In September 2026, Basecamp Research Ltd raised USD 140 million in series C funding led by investor Section 32, with participation from Singular, True Ventures, NVentures, Firebrand, Redalpine, Catalio Capital Management, European Tech Collective, Inception Fund, King Philanthropies, Menlo Ventures, NATO Innovation Fund, PostScriptum Oy, Rockefeller Foundation, Sovereign AI. Basecamp creates and offers protein products and drugs for the healthcare, nutrition, and cosmetic sectors. The company offers a biological data platform that uses artificial intelligence to make base-data graphs with geological and environmental tags. The company will use the September 2026 funding to support the further development of its AI-driven drug discovery platform.

## Funding rounds

- Series C, Sep 22, 2026, $140M — Menlo Ventures, Rockefeller Foundation, True Ventures, Redalpine, Firebrand, Section 32, Nventures, Catalio Capital Management, NATO Innovation Fund, Singular, King Philanthropies, Inception Fund, Sovereign AI, European Tech Collective, PostScriptum Oy
- Series B, Sep 9, 2024, $58M — True Ventures, Hummingbird Ventures, Redalpine, Section 32, Singular
- Series A, Aug 5, 2022, $19M — True Ventures, Hummingbird Ventures, SystemiQ, Blue Horizon, Valo Health, Inc.

## Investors

- True Ventures (https://capitalatlas.ai/funds/true-ventures) — Series A, Series B, Series C
- Hummingbird Ventures (https://capitalatlas.ai/funds/hummingbird-ventures) — Series A, Series B
- SystemiQ (https://capitalatlas.ai/funds/systemiq) — Series A
- Blue Horizon (https://capitalatlas.ai/funds/blue-horizon) — Series A
- Valo Health, Inc. — Series A
- Redalpine (https://capitalatlas.ai/funds/redalpine) — Series B, Series C
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series B, Series C
- Singular (https://capitalatlas.ai/funds/singular) — Series B, Series C
- Menlo Ventures (https://capitalatlas.ai/funds/menlo-ventures) — Series C
- Rockefeller Foundation — Series C
- Firebrand (https://capitalatlas.ai/funds/firebrand) — Series C
- Nventures — Series C
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Series C
- NATO Innovation Fund (https://capitalatlas.ai/funds/nato-innovation-fund) — Series C
- King Philanthropies — Series C
- Inception Fund (https://capitalatlas.ai/funds/inception-fund) — Series C
- Sovereign AI (https://capitalatlas.ai/funds/sovereign-ai) — Series C
- European Tech Collective — Series C
- PostScriptum Oy — Series C